Vigilant Biosciences Announces Agreement with Biotech-IgG AB for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Scandinavia March 11, 2015 COLOGNE, Germany Vigilant
Vigilant Biosciences Enters Agreement with BL&H Co., Ltd. for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Korea March 10, 2015 COLOGNE, Germany
Vigilant Biosciences to Exhibit and Present at International Dental Show 2015 March 6, 2015 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer
Vigilant Biosciences Closes $5.5 Million Series B Round of Funding February 24, 2015 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of
Vigilant Biosciences, Inc. Marks Significant Milestone with ISO 13485:2003 Certification December 10, 2014 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading developer of solutions that
Vigilant Closes $2.3 Million Initial Round of Financing March 25, 2014 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that
